Your browser doesn't support javascript.
loading
Broad cross-presentation of the hematopoietically derived PR1 antigen on solid tumors leads to susceptibility to PR1-targeted immunotherapy.
Alatrash, Gheath; Mittendorf, Elizabeth A; Sergeeva, Anna; Sukhumalchandra, Pariya; Qiao, Na; Zhang, Mao; St John, Lisa S; Ruisaard, Kathryn; Haugen, Christine E; Al-Atrache, Zein; Jakher, Haroon; Philips, Anne V; Ding, Xiaoling; Chen, Jie Qing; Wu, Yun; Patenia, Rebecca S; Bernatchez, Chantale; Vence, Luis M; Radvanyi, Laszlo G; Hwu, Patrick; Clise-Dwyer, Karen; Ma, Qing; Lu, Sijie; Molldrem, Jeffrey J.
  • Alatrash G; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. galatras@mdanderson.org
J Immunol ; 189(11): 5476-84, 2012 Dec 01.
Article en En | MEDLINE | ID: mdl-23105141
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Neoplasias de la Mama / Elastasa de Leucocito / Mieloblastina / Inmunoterapia / Melanoma / Antígenos de Neoplasias Tipo de estudio: Prognostic_studies Límite: Female / Humans Idioma: En Año: 2012 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Neoplasias de la Mama / Elastasa de Leucocito / Mieloblastina / Inmunoterapia / Melanoma / Antígenos de Neoplasias Tipo de estudio: Prognostic_studies Límite: Female / Humans Idioma: En Año: 2012 Tipo del documento: Article